NASDAQ:CRSP   CRISPR Therapeutics AG
Catalysts coming in 2022 and weekly trend changes based on heiken ashii candles, plus the bounce at 74+- which was prior resistance, plus analyst ratings make this an attractive buy for me at these levels.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.